Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy, safety and tolerability of AEB071 in the treatment of
active, moderate to severe ulcerative colitis in patients who have failed conventional
therapy using mesalamine or steroids